08/06/2025
1:12 PM | MORGAN STANLEY (Filed by)
Pliant Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/17/2025
7:12 PM | BlackRock, Inc. (Filed by)
Pliant Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
06/09/2025
7:42 PM | CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:43 PM | Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:43 PM | Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:43 PM | Cline Darren S (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:43 PM | Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:44 PM | Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:44 PM | MCCOURT Thomas A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:44 PM | Knobil Katharine (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
7:44 PM | Bruhn Suzanne Louise (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PLRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/09/2025
4:29 PM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
3:39 PM | Paradigm Biocapital Advisors LP (Filed by)
Pliant Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
9:45 AM | Pliant Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025
3:13 PM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:17 PM | Pliant Therapeutics (Filer)
| Form DEF 14A | |
04/23/2025
3:19 PM | Pliant Therapeutics (Filer)
| Form DEFA14A | |
04/10/2025
3:30 PM | Pliant Therapeutics (Filer)
| Form PRE 14A | |
03/13/2025
7:49 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
7:05 AM | Pliant Therapeutics (Filer)
| Form 8-A12B | |
03/10/2025
4:24 PM | Pliant Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13D | |
03/07/2025
9:01 AM | FMR LLC (Filed by)
Pliant Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/03/2025
3:18 PM | Pliant Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
7:01 PM | Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
8:00 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
6:01 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
5:14 PM | Cheung Lily (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:01 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:04 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:07 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:10 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:58 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
4:55 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
4:58 PM | Cheung Lily (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:00 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:02 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:05 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:07 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:23 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:00 PM | Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G | |
11/12/2024
10:53 AM | Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
10/04/2024
4:34 PM | Paradigm Biocapital Advisors LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
09/27/2024
3:11 PM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free PLRX Stock Alerts